We now have the technology to identify people who are on a fast track to developing dementia.
Scientists explain why commercial gene testing should be used with caution.
After the failure of multiple drug trials the outlook for an Alzheimer’s drug is bleak. This shouldn’t be a surprise. We don’t know the cause or even how to diagnose the disease.
Alzheimer’s is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn’t easy.